Clinical Management of Tourette Syndrome with Clonidine
The demonstration of clonidine’s effectiveness in Tourette syndrome (TS) (Ashanuddin et al.,1980; Cohen et al., 1979, 1980; Dorsey, 1981) substantially expanded the pharmacological options in the management of this condition. For the preceding decade, the only clearly effective medication was haloperidol, and before that, TS sufferers received a host of treatments ranging from psychotherapy to behavior modification to electroconvulsive treatment.
KeywordsNeuropsychiatric Disorder Tourette Syndrome Behavioral Disturbance Attention Deficit Disorder Subjective Distress
Unable to display preview. Download preview PDF.
- Ashanuddin, K., Hall, K., Kowall, M., and Prosen, H., 1980, Tourette’s syndrome-treatment with clonidine, A centrally acting alpha-adrenergic agonist, Drug. Intell., Clin. Pharmacol. 14 (32): 288–289.Google Scholar
- Brun, R. D., 1982, Clonidine treatment of Tourette’s syndrome, Adv. Neurol. 35: 403–405.Google Scholar
- Cohen, D. J., Young, J. G., Nathanson, J. A., and Shaywitz, B. A., 1979, Clonidine in Tourette’s syndrome, Lancet H 8142: 551–553.Google Scholar
- Cohen, D. J., et al.,1982, Stimulant medications in Tourette’s syndrome, DAMA 248:1062–1063.Google Scholar
- Leckman, J. F., Cohen, D. J., Detlor, J., Young, J. G., Harchurik, D., and Shawitz, B. A., 1982, Clonidine in the treatment of Tourette syndrome: A review of data, in: Gilles de la Tourette Syndrome, Advances in Neurology, Vol. 35, pp. 391–402, Raven Press, New York.Google Scholar
- Shapiro, A. K., and Shapiro, E., 1982, Advances in Neurology, Vol. 35, pp. 283–286, Raven Press, New York.Google Scholar